MASEP-INFINI MEDICAL SCIENCE TECHNOLOGY DEVELOPMENT CO., LTD. – Trademark Portfolio
Entity Type: 03
MASEP-INFINI MEDICAL SCIENCE TECHNOLOGY DEVELOPMENT CO., LTD. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 2 filings in this category. Currently, 2 trademarks are registered. Notable registered marks include MASEP and MASEP INFINI. The owner is based in CITY OF INDUSTRY, CA.
17870 CASTLETON STREET, SUITE 395
CITY OF INDUSTRY, CA 91748
Showing of trademarks Trademarks
Trademark Classifications
MASEP-INFINI MEDICAL SCIENCE TECHNOLOGY DEVELOPMENT CO., LTD.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Frequently Asked Questions
How many trademarks does MASEP-INFINI MEDICAL SCIENCE TECHNOLOGY DEVELOPMENT CO., LTD. have?
MASEP-INFINI MEDICAL SCIENCE TECHNOLOGY DEVELOPMENT CO., LTD. has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.
What trademark classes does MASEP-INFINI MEDICAL SCIENCE TECHNOLOGY DEVELOPMENT CO., LTD. file in?
MASEP-INFINI MEDICAL SCIENCE TECHNOLOGY DEVELOPMENT CO., LTD. files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are MASEP-INFINI MEDICAL SCIENCE TECHNOLOGY DEVELOPMENT CO., LTD.'s most well-known trademarks?
MASEP-INFINI MEDICAL SCIENCE TECHNOLOGY DEVELOPMENT CO., LTD.'s registered trademark portfolio includes well-known marks such as MASEP and MASEP INFINI. These are among 2 currently registered trademarks in the portfolio.
What is MASEP-INFINI MEDICAL SCIENCE TECHNOLOGY DEVELOPMENT CO., LTD.'s trademark registration success rate?
MASEP-INFINI MEDICAL SCIENCE TECHNOLOGY DEVELOPMENT CO., LTD. has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.